Early increase of serum ferritin among COVID-19 patients is associated with need of invasive mechanical ventilation and with in-hospital death

References

• Zhu N, Zhang D, Wang W, China Novel Coronavirus Investigating and Research Team, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. 2022 [cited 2022 Mar 27]. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19
   Google Scholar
• COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. 2022 [cited 2022 Mar 27]. https://coronavirus.jhu.edu/map.html
   Google Scholar
• Irons NJ, Raftery AE. Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys. Proc Natl Acad Sci USA. 2021;118(31):e2103272118.
   PubMed Web of Science ®Google Scholar
• Wu SL, Mertens AN, Crider YS, et al. Substantial underestimation of SARS-CoV-2 infection in the United States. Nat Commun. 2020;11(1):4507.
   PubMed Web of Science ®Google Scholar
• Shoaib N, Noureen N, Munir R, et al. COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes. Farooqui M, editor. PLoS One. 2021;16(8):e0255999.
   PubMed Web of Science ®Google Scholar
• Iroungou BA, Mangouka LG, Bivigou-Mboumba B, et al. Demographic and clinical characteristics associated with severity, clinical outcomes, and mortality of COVID-19 infection in Gabon. JAMA Netw Open. 2021;4(9):e2124190.
   PubMed Web of Science ®Google Scholar
• Cao Y, Hiyoshi A, Montgomery S. COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data. BMJ Open. 2020;10(11):e043560.
   PubMed Web of Science ®Google Scholar
• Smith C, Odd D, Harwood R, et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. 2022;28(1):185–192.
   PubMed Web of Science ®Google Scholar
• Pijls BG, Jolani S, Atherley A, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a Meta-analysis of 59 studies. BMJ Open. 2021;11(1):e044640.
   PubMed Web of Science ®Google Scholar
• Webber BJ, Lang MA, Stuever DM, et al. Health-Related behaviors and odds of COVID-19 hospitalization in a military population. Prev Chronic Dis. 2021;18:E96.
   PubMed Web of Science ®Google Scholar
• Booth JH, Bryant R, Powers SC, et al. Transthoracic echocardiography does not reliably predict involvement of the aortic valve in patients with a discrete subaortic shelf. Cardiol Young. 2010;20(3):284–289.
   PubMed Web of Science ®Google Scholar
• Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: a Meta-analysis. Inter J Infect Dis. 2020;96:467–474.
   PubMed Web of Science ®Google Scholar
• Huang I, Pranata R, Lim MA, et al. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a Meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175.
   Web of Science ®Google Scholar
• Zhou B, She J, Wang Y, et al. Utility of Ferritin, Procalcitonin, and C-reactive Protein in Severe Patients with 2019 Novel Coronavirus Disease [Internet]. 2020 [cited 2022 Jul 4]. Available from: https://www.researchsquare.com/article/rs-18079/v1
   Google Scholar
• Di Fusco M, Shea KM, Lin J, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308–317.
   PubMed Web of Science ®Google Scholar
• Gulhar R, Ashraf MA, Jialal I. Physiology, acute phase reactants. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Bland JM, Altman DG, Statistics n Calculating correlation coefficients with repeated observations: part 1–correlation within subjects. BMJ. 1995;310(6977):446–446.
   PubMed Web of Science ®Google Scholar
• Veiga VC, Prats JAGG, Farias DLC, et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021;372:n84.
   PubMed Web of Science ®Google Scholar
• Abani O, Abbas A, Abbas F, et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2021;397(10285):1637–1645.
   PubMed Web of Science ®Google Scholar
• Tan LY, Komarasamy TV, RMT, Balasubramaniam V. Hyperinflammatory immune response and COVID-19: a double edged sword. Front Immunol. 2021;12(742941):742941.
   PubMedGoogle Scholar
• Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and Meta-analysis. BMJ Ebm. 2021;26(3):107–108.
   Google Scholar
• Yormaz B, Ergun D, Tulek B, et al. The evaluation of prognostic value of acute phase reactants in the COVID-19. Bratisl Lek Listy. 2020;121(9):628–633.
   PubMed Web of Science ®Google Scholar
• Sayit AT, Elmali M, Deveci A, et al. Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia. Rev Inst Med Trop Sao Paulo. 2021;63:e51.
   PubMed Web of Science ®Google Scholar
• Qin R, He L, Yang Z, et al. Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic review and Meta-analysis. Clinic Rev Allerg Immunol. 2022. DOI:10.1007/s12016-021-08908-8
   PubMed Web of Science ®Google Scholar
• Peiró ÓM, Carrasquer A, Sánchez-Gimenez R, et al. Biomarkers and short-term prognosis in COVID-19. Biomarkers. 2021;26(2):119–126.
   PubMed Web of Science ®Google Scholar
• Samprathi M, Jayashree M. Biomarkers in COVID-19: an up-to-Date review. Front Pediatr. 2020;8:607647.
   PubMed Web of Science ®Google Scholar
• Alroomi M, Rajan R, Omar AA, et al. Ferritin level: a predictor of severity and mortality in hospitalized COVID‐19 patients. Immun Inflamm Dis. 2021;9(4):1648–1655.
   PubMed Web of Science ®Google Scholar
• Quartuccio L, Sonaglia A, Pecori D, et al. Higher levels of IL‐6 early after tocilizumab distinguish survivors from nonsurvivors in COVID‐19 pneumonia: a possible indication for deeper targeting of IL‐6. J Med Virol. 2020;92(11):2852–2856.
   PubMed Web of Science ®Google Scholar
• Zhou J, He W, Liang J, et al. Association of interleukin-6 levels with morbidity and mortality in patients with coronavirus disease 2019 (COVID-19). Jpn J Infect Dis. 2021;74(4):293–298.
   PubMed Web of Science ®Google Scholar
• Santa Cruz A, Mendes-Frias A, Oliveira AI, et al. Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia. Front Immunol. 2021;12:613422.
   PubMed Web of Science ®Google Scholar
• Zodpey SP, Negandhi H, Kamal VK, et al. Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020. Serra R, editor. PLoS One. 2021;16(12):e0261529.
   PubMed Web of Science ®Google Scholar
• Cullis JO, Fitzsimons EJ, Griffiths WJ, et al.; the British Society for Haematology. Investigation and management of a raised serum ferritin. Br J Haematol. 2018 May;181(3):331–340.
   PubMed Web of Science ®Google Scholar
• Lalueza A, Ayuso B, Arrieta E, et al. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect. 2020;26(11):1557.e9-1557–e15.
   Web of Science ®Google Scholar
• Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401–409.
   PubMed Web of Science ®Google Scholar
• Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia. 2021;13(1):5.
   Web of Science ®Google Scholar
• Sonnweber T, Boehm A, Sahanic S, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respir Res. 2020;21(1):276.
   PubMed Web of Science ®Google Scholar
• Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175–185.
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen P, Zhai B, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother. 2020;127:110108.
   PubMed Web of Science ®Google Scholar